Policy | April 03, 2026
EMA moves to cut animal testing with “virtual control groups” in preclinical research
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
This marks a meaningful step in the company's continued expansion in the region
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
The new regimen, delivering 50 mg/5 mL and 28 mg/5 mL doses, offers a higher concentration of the drug for both loading and maintenance phases
The company’s broader OX2R portfolio includes clinical and preclinical assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions
The program, which has been active for over a decade, will now expand its reach, focusing on equitable access to education, resources, and community-driven solutions for patients and care partners
Subscribe To Our Newsletter & Stay Updated
